Navigation Links
Helix BioPharma announces $16.9 million private placement of common shares
Date:12/17/2007

AURORA, Ontario, Dec. 17 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP") today announced that it has received subscriptions for the purchase, by way of private placement, of a total of 10,040,000 common shares at $1.68 per share, for gross proceeds totaling CDN$16,867,200. Proceeds from the placement will be used for working capital, primarily to fund the Company's research and development initiatives.

The Company expects to close the private placement within the next ten days.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP" and quoted on the Frankfurt, Berlin, Munich and Stuttgart Stock Exchanges under the same symbol.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release. This News Release contains forward-looking statements regarding a proposed private placement and the Company's activities, which statements can be identified by the words "will", "anticipates", and "developing". Actual results or events could differ materially from these forward-looking statements due to numerous factors, including without limitation, the risk that the proposed placement may not close as anticipated or at all, research & development risks, Helix's need for additional future capital, the risk of unanticipated expenses, and possible changes in business strategy or plans. These and other risks and uncertainties are contained in Helix's latest Annual Information Form at http://www.sedar.com'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
10. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
11. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 Human Longevity, ... therapeutic company focused on extending the healthy, high performance ... Franz Och , Ph.D., an expert in machine learning ... Och comes to HLI from Google where he was ... He will report directly to HLI Co-Founder and CEO, ...
(Date:7/29/2014)... (July 29, 2014) Tough, ultralight foam of ... shape through a chemical process invented at Rice University. ... looks like a nanoscale building, with floors and walls ... pair of two-dimensional materials: floors and walls of graphene ... nitride platelets. , The researchers say the foam ...
(Date:7/29/2014)... , July 29, 2014  The Society ... new and updated program for the 9 th ... 12, 2014 in Amelia Island , Florida.  ... and investigators remains unchanged, however, the topics and ... and networking opportunity among all stakeholders with a ...
(Date:7/29/2014)... Second generation biofuels are a viable solution to the dilemma ... gas is very cheap, this is affecting the biofuels market ... they could be in comparison to natural gas. This, ... difficult for renewable energy developers to get the economics to ... reasons, certain companies have shifted their focused within renewable energy. ...
Breaking Biology Technology:Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 2Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 3Tough foam from tiny sheets 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2
... NORWOOD, Mass., Aug. 24 Advanced Instruments has introduced a ... experience when purchasing osmometers, cryoscopes, and microbiological laboratory instruments. The ... es.com , was developed from the perspective of ... application information, scientific materials, and technical support. , , ...
... SAN DIEGO, Aug. 24 Orexigen((R)) Therapeutics, Inc. (Nasdaq: ... joined the Company as Chief Commercial Officer. Mr. Booth ... to Orexigen. Most recently he served as President of ... commercial, medical and scientific affairs, business development and all support ...
... August 24 Foamix Ltd., a leading,developer of topical ... been awarded US Patent #7575739 pertaining to its foam,technology. ... of heat and chemical burns, wounds, bacterial, fungal and ... the Company,s CEO stated, "The novelty of our foam,technology ...
Cached Biology Technology:Advanced Instruments Introduces Next-Generation Web Site 2Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Foamix Receives US Patent on Novel Foam Technology 2
(Date:7/29/2014)... have been plaguing the Northern Territories in Canada and ... in the U.S. continue on. NASA,s Aqua satellite ... Spectroradiometer, MODIS, instrument on July 26, 2014. Actively burning ... red. Copious amount of smoke are drifting northward in ... residents of Yellowknife. Fire has caused power outages ...
(Date:7/29/2014)... easier method to create DNAprotein conjugates. The method ... diseases. , DNA linked to proteins including ... be used in diagnostic techniques, nanotechnology and other ... DNA can be used for purposes such ... material. The method also provides easier access to ...
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
Breaking Biology News(10 mins):New method provides researchers with efficient tool for tagging proteins 2
... This press release is available in French . ... people are not slower but rather wiser than young brains, ... performance, according research undertaken at the University Geriatrics Institute of ... the Univeristy of Montreal. "The older brain has experience and ...
... Society of Interventional Radiology Foundation,s Discovery Campaign, which ... medicine into new areas of discovery, announced a ... manufacturer of medical devices, pharmaceuticals and medical supplies, ... is a "Visionary" level supporter. "Collaboration ...
... one way that old-fashioned newsprint beats the Internet. Tulane ... "TU-103," that can use paper to produce butanol, a ... They are currently experimenting with old editions of the ... success., ,TU-103 is the first bacterial strain from nature ...
Cached Biology News:Clinical study shows young brains lack the wisdom of their elders 2Cars could run on recycled newspaper, Tulane scientists say 2
...
... Fully adjustable mixing angle, Variable speed, Digital ... a number of different sized tubes, Spillage ... cultures, keeping biological samples in suspension and ... be used in incubators up to 60C ...
... The DNA Engine Opticon 2 real-time PCR ... LEDs for fluorescence excitation (470-505 nm) and ... nm, 540-700 nm). The Opticon 2 system ... cycler, which includes a thermal gradient feature. ...
... Multicolor capability allows detection of SYBR ... channel, and a range of fluorophores in ... VIC, and TAMRA for a multitude ... discrimination. DNA Engine thermal cycler offers precision ...
Biology Products: